Adaptimmune Therapeutics plc (ADAP)
USD 0.25
(-3.06%)
USD 0.25
(-3.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 50.42 Million USD | 150.37% |
| 2022 | -100.57 Million USD | 4.16% |
| 2021 | -104.94 Million USD | -19.78% |
| 2020 | -87.61 Million USD | 9.1% |
| 2019 | -96.37 Million USD | -261.97% |
| 2018 | 59.5 Million USD | 57.28% |
| 2017 | 37.83 Million USD | 166.47% |
| 2016 | 14.19 Million USD | 32.43% |
| 2015 | 10.72 Million USD | 1673.21% |
| 2014 | 604.62 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.84 Million USD | 207.87% |
| 2024 Q2 | 125.62 Million USD | 4308.65% |
| 2023 Q3 | 4.44 Million USD | 53.72% |
| 2023 Q4 | -2.64 Million USD | -159.45% |
| 2023 FY | 50.65 Million USD | 150.37% |
| 2023 Q1 | 45.73 Million USD | 480.4% |
| 2023 Q2 | 2.89 Million USD | -93.68% |
| 2022 Q3 | -26.17 Million USD | 10.37% |
| 2022 Q2 | -29.2 Million USD | 11.98% |
| 2022 FY | -100.57 Million USD | 4.16% |
| 2022 Q1 | -33.17 Million USD | -18.12% |
| 2022 Q4 | -12.02 Million USD | 54.06% |
| 2021 Q2 | -25.77 Million USD | -7.07% |
| 2021 FY | -104.94 Million USD | -19.78% |
| 2021 Q4 | -28.08 Million USD | -4.0% |
| 2021 Q1 | -24.07 Million USD | 0.84% |
| 2021 Q3 | -27 Million USD | -4.79% |
| 2020 Q2 | -19.95 Million USD | 2.66% |
| 2020 Q3 | -22.87 Million USD | -14.61% |
| 2020 Q4 | -24.27 Million USD | -6.12% |
| 2020 FY | -87.61 Million USD | 9.1% |
| 2020 Q1 | -20.5 Million USD | -4.47% |
| 2019 Q1 | -22.01 Million USD | -3.42% |
| 2019 FY | -96.37 Million USD | -261.97% |
| 2019 Q4 | -19.62 Million USD | 33.2% |
| 2019 Q3 | -29.38 Million USD | -15.88% |
| 2019 Q2 | -25.35 Million USD | -15.15% |
| 2018 Q3 | 17.3 Million USD | 198.42% |
| 2018 Q4 | -21.29 Million USD | -223.01% |
| 2018 FY | 59.5 Million USD | 57.28% |
| 2018 Q1 | -17.53 Million USD | 16.01% |
| 2018 Q2 | -17.58 Million USD | -0.29% |
| 2017 Q2 | -16.07 Million USD | -662.48% |
| 2017 Q1 | 2.85 Million USD | -66.53% |
| 2017 FY | 37.83 Million USD | 166.47% |
| 2017 Q4 | -20.87 Million USD | -762.58% |
| 2017 Q3 | 3.15 Million USD | 119.61% |
| 2016 Q1 | 2.91 Million USD | -27.61% |
| 2016 Q3 | 2.41 Million USD | 636.59% |
| 2016 FY | 14.19 Million USD | 32.43% |
| 2016 Q4 | 8.53 Million USD | 253.31% |
| 2016 Q2 | 328 Thousand USD | -88.76% |
| 2015 Q4 | 4.03 Million USD | 2.31% |
| 2015 FY | 10.72 Million USD | 1673.21% |
| 2015 Q3 | 3.94 Million USD | 41.58% |
| 2015 Q2 | 2.78 Million USD | 2.02% |
| 2015 Q1 | 2.72 Million USD | 20.29% |
| 2014 Q1 | 295.85 Thousand USD | 0.0% |
| 2014 Q2 | 521.4 Thousand USD | 76.23% |
| 2014 FY | 604.62 Thousand USD | 0.0% |
| 2014 Q3 | 1.53 Million USD | 194.04% |
| 2014 Q4 | 2.26 Million USD | 47.92% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -32.607% |
| Alkermes plc | 1.37 Billion USD | 96.332% |
| Agenus Inc. | 139.61 Million USD | 63.884% |
| Aptorum Group Limited | -1.11 Million USD | 4623.592% |
| Ardelyx, Inc. | 106.66 Million USD | 52.725% |
| Dyadic International, Inc. | 922.95 Thousand USD | -5363.303% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -139.419% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 28939.554% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 477.486% |
| Novavax, Inc. | 639.93 Million USD | 92.12% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 207.654% |
| Pyxis Oncology, Inc. | -2 Million USD | 2621.197% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 9857.974% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -164.79% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 114212.295% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 9668.11% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 151.339% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -6187.274% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 61592.611% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 62.723% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -540.629% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 152.01% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 96.678% |
| AlloVir, Inc. | -398 Thousand USD | 12769.332% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 79.054% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -11792.439% |
| Bicycle Therapeutics plc | -129.52 Million USD | 138.931% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -41919.951% |
| ChromaDex Corporation | 50.78 Million USD | 0.701% |
| Chimerix, Inc. | 324 Thousand USD | -15462.945% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 261.783% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 164.981% |
| CRISPR Therapeutics AG | 240.95 Million USD | 79.073% |
| Precision BioSciences, Inc. | 40.47 Million USD | -24.59% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 151.368% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12.841% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12.841% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -204.18% |
| ImmuCell Corporation | 4.39 Million USD | -1046.967% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 147.515% |
| Immix Biopharma, Inc. | -5468.00 USD | 922264.247% |
| Incyte Corporation | 3.44 Billion USD | 98.534% |
| Innoviva, Inc. | 261.06 Million USD | 80.685% |
| IO Biotech, Inc. | -756 Thousand USD | 6769.833% |
| Jaguar Health, Inc. | 7.72 Million USD | -552.822% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 7693.967% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 57.893% |
| ContextLogic Inc. | 59 Million USD | 14.536% |
| MiMedx Group, Inc. | 266.84 Million USD | 81.104% |
| MEI Pharma, Inc. | 49.32 Million USD | -2.224% |
| NextCure, Inc. | -3.68 Million USD | 1468.728% |
| Onconetix, Inc. | -1.12 Million USD | 4573.519% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 274.068% |
| Opthea Limited | 21.72 Thousand USD | -232054.424% |
| Psyence Biomedical Ltd. | -240.00 USD | 21010075.417% |
| Vaxcyte, Inc. | -75 Million USD | 167.232% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 88059.985% |
| Precigen, Inc. | 106 Thousand USD | -47469.756% |
| Pharming Group N.V. | 220.1 Million USD | 77.091% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -9691.057% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -4897.417% |
| PureTech Health plc | -1.6 Million USD | 3245.598% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 54.065% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 127.796% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 211.25% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 329.335% |
| Acelyrin, Inc. | -115 Thousand USD | 43946.905% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 501780.838% |
| Summit Therapeutics Inc. | -2.05 Million USD | 2559.704% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 8930.813% |
| Senti Biosciences, Inc. | -2.68 Million USD | 1979.387% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1144.728% |
| Elevation Oncology, Inc. | -39 Thousand USD | 129392.156% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1150.937% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1379.131% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -73.106% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -10066.117% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 91779.893% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 51.562% |
| Seer, Inc. | 7.02 Million USD | -617.574% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1051.757% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -134.04% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 42655.081% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 35287.431% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -8179.793% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 58.145% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 83.925% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1008578.82% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1858.972% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 99477.101% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -71.586% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 21834.457% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 10348.768% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 810.396% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 10725.745% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 484945.587% |
| Soligenix, Inc. | 97.31 Thousand USD | -51717.308% |
| Century Therapeutics, Inc. | -10.8 Million USD | 566.5% |
| Kura Oncology, Inc. | -849 Thousand USD | 6039.216% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 175.143% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 34402.001% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 49.087% |
| Autolus Therapeutics plc | -4.86 Million USD | 1136.037% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -21.838% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 30114.251% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 46.767% |
| GRI Bio, Inc. | 10.84 Million USD | -365.123% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1885.205% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 680.453% |
| IGM Biosciences, Inc. | -211.66 Million USD | 123.823% |
| INmune Bio, Inc. | 155 Thousand USD | -32431.575% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 18.591% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3447.556% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 7876.024% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 172348.21% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -12443.269% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 2626.25% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 16209.885% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 46.619% |
| Verastem, Inc. | -62 Thousand USD | 81428.937% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -1970.798% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 19419.518% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1565.806% |
| Histogen Inc. | 3.76 Million USD | -1237.86% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -8651.437% |
| Surrozen, Inc. | -27.23 Million USD | 285.178% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1035.683% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 4284.976% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 296.608% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -151.466% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 2546763.687% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -731.197% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 75212.751% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 67.425% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -34484.322% |
| Apollomics, Inc. | 127 Thousand USD | -39603.891% |
| Amarin Corporation plc | 165.54 Million USD | 69.54% |
| Mesoblast Limited | -9.81 Million USD | 613.744% |
| Turnstone Biologics Corp. | 16.5 Million USD | -205.489% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 145.637% |
| Synaptogenix, Inc. | -6347.00 USD | 794553.143% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 98970.473% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 68.752% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 97.131% |
| Better Therapeutics, Inc. | -2.72 Million USD | 1947.708% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 144.957% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 85.085% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 442105.093% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 905.494% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4650.897% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -589.04% |
| Insmed Incorporated | 239.63 Million USD | 78.958% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -1309.277% |
| OmniAb, Inc. | 14.66 Million USD | -243.792% |
| Alector, Inc. | -95.05 Million USD | 153.048% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 59.86% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 216.016% |
| Zai Lab Limited | 170.9 Million USD | 70.496% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 38.415% |
| Aura Biosciences, Inc. | -1.29 Million USD | 3993.741% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -38687.647% |
| Immunic, Inc. | -111 Thousand USD | 45526.974% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -218.052% |
| Veracyte, Inc. | 248.14 Million USD | 79.68% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.721% |
| FibroGen, Inc. | 128.9 Million USD | 60.883% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 8940515.071% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 532.197% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.516% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -12862.453% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 85.81% |
| TG Therapeutics, Inc. | 219.1 Million USD | 76.987% |
| Galecto, Inc. | -830 Thousand USD | 6175.174% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 3740.718% |
| Fortrea Holdings Inc. | 424 Million USD | 88.108% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 158.519% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 8993.111% |
| XBiotech Inc. | -1.74 Million USD | 2991.281% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4650.897% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 208.506% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 166.757% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 31.305% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -200.089% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 87.039% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 201.565% |
| Vaxxinity, Inc. | -2.23 Million USD | 2357.115% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 84.568% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 545.29% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -106.224% |
| NexImmune, Inc. | -1.02 Million USD | 5019.543% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -933676.685% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 809.631% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.554% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 75554.444% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1519.993% |
| Ainos, Inc. | -253.73 Thousand USD | 19972.835% |
| Pluri Inc. | 322 Thousand USD | -15559.609% |
| Prothena Corporation plc | -129.2 Million USD | 139.028% |
| Celularity Inc. | 6.75 Million USD | -646.468% |
| Rallybio Corporation | -150 Thousand USD | 33715.961% |
| Cue Biopharma, Inc. | -32.6 Million USD | 254.641% |
| MeiraGTx Holdings plc | 287 Thousand USD | -17469.317% |
| Omeros Corporation | -69.77 Million USD | 172.262% |
| Humacyte, Inc. | -76.55 Million USD | 165.871% |
| Immunocore Holdings plc | 248.39 Million USD | 79.7% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 432.414% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 19.169% |
| Blueprint Medicines Corporation | 236.58 Million USD | 78.687% |
| CalciMedica, Inc. | -58 Thousand USD | 87037.829% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 3636.041% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -73.547% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1872.994% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 263.369% |
| Pulmatrix, Inc. | -8.22 Million USD | 713.43% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 4409.739% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 12737.579% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 112.644% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1716.696% |
| Cytokinetics, Incorporated | -322.59 Million USD | 115.631% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -5748.933% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 14887.079% |
| Vor Biopharma Inc. | -3.49 Million USD | 1543.985% |
| Roivant Sciences Ltd. | 109.23 Million USD | 53.839% |
| Evogene Ltd. | 1.39 Million USD | -3504.285% |
| ProKidney Corp. | -3.16 Million USD | 1691.163% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 214.83% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -635.364% |
| CorMedix Inc. | -205.56 Thousand USD | 24629.797% |
| BioLineRx Ltd. | 1.1 Million USD | -4450.897% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 164.095% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 152899.821% |
| Atai Life Sciences N.V. | -5000.00 USD | 1008578.82% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 41478.922% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 52624.939% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 3730.233% |
| Sagimet Biosciences Inc. | 2 Million USD | -2421.197% |
| MediciNova, Inc. | 979.7 Thousand USD | -5046.849% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 159.801% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 53427.63% |
| GeoVax Labs, Inc. | -20.72 Million USD | 343.35% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 79.38% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1300.284% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 94.22% |
| Mereo BioPharma Group plc | 7.42 Million USD | -579.019% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 16365.787% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 420299.508% |
| Absci Corporation | -41.84 Million USD | 220.49% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1008578.82% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 166.023% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 2148.921% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 76.408% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 5458.548% |
| Allakos Inc. | -6.14 Million USD | 921.103% |
| Imunon, Inc. | -720 Thousand USD | 7103.277% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 173.082% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 89.404% |
| BioAtla, Inc. | -103.73 Million USD | 148.61% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 442105.093% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 28428.057% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 120.766% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 16313.486% |
| XOMA Corporation | 3.86 Million USD | -1205.981% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 171.947% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -240.84% |
| aTyr Pharma, Inc. | -2.38 Million USD | 2211.555% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -304.687% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 173975.659% |
| Viridian Therapeutics, Inc. | -1 Million USD | 5102.375% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -387876369.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 1260698.525% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 92.083% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -25797.211% |
| UroGen Pharma Ltd. | 73.35 Million USD | 31.258% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 288.896% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -434214.737% |
| Orgenesis Inc. | -5.72 Million USD | 980.768% |
| Entera Bio Ltd. | -56 Thousand USD | 90142.752% |
| GH Research PLC | -315 Thousand USD | 16107.6% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 26779.334% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 9704.56% |
| Xencor, Inc. | -85.26 Million USD | 159.141% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 22918.638% |
| Replimune Group, Inc. | -2.65 Million USD | 1999.207% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 5136.169% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 71.647% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -25797.211% |
| Portage Biotech Inc. | -54 Thousand USD | 93477.669% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 53427.63% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 13475.051% |
| OncoCyte Corporation | 413 Thousand USD | -12109.187% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1121878.443% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 22713586.937% |
| Purple Biotech Ltd. | -196 Thousand USD | 25826.501% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -462.265% |
| scPharmaceuticals Inc. | 9.78 Million USD | -415.477% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 582.759% |
| HilleVax, Inc. | -2.15 Million USD | 2438.773% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 52083.444% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 336169.988% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 7648.494% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 219334.526% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 671867.468% |
| Savara Inc. | -44.26 Million USD | 213.922% |
| Curis, Inc. | 9.81 Million USD | -413.953% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1720.673% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 40507.684% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 3016.364% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 22215.764% |
| BeiGene, Ltd. | 2.07 Billion USD | 97.574% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 1903.496% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 112.617% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 11.05% |
| Erasca, Inc. | -3.73 Million USD | 1451.124% |
| bluebird bio, Inc. | -4.03 Million USD | 1351.214% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 178794.241% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 97.352% |
| DBV Technologies S.A. | 15.72 Million USD | -220.6% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 178794.241% |
| Moderna, Inc. | 2.15 Billion USD | 97.66% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 5610.813% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -529.827% |
| Molecular Templates, Inc. | 50.39 Million USD | -0.057% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 9507.452% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 62.311% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 910.414% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 228.165% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 145.375% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1505.35% |
| MacroGenics, Inc. | 50.52 Million USD | 0.204% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 926.893% |
| Prime Medicine, Inc. | -147.9 Million USD | 134.092% |
| Aditxt, Inc. | -111.66 Thousand USD | 45258.464% |
| Adagene Inc. | 18.11 Million USD | -178.409% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -10232.775% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 64.035% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 68.053% |
| SciSparc Ltd. | 2.19 Million USD | -2196.172% |
| Vericel Corporation | 135.57 Million USD | 62.808% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 201401.214% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 162852.376% |
| Generation Bio Co. | -73.91 Million USD | 168.223% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 11638.659% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 7.681% |
| Invivyd, Inc. | -2.02 Million USD | 2586.388% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 116.761% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 48847.985% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 47.676% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 48.698% |
| ADMA Biologics, Inc. | 88.21 Million USD | 42.842% |
| Clene Inc. | 533 Thousand USD | -9360.402% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -109.148% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 5368.959% |
| GeoVax Labs, Inc. | -20.72 Million USD | 343.35% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -2436.416% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 26049.454% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1.243% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 810.997% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 6131.572% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 39.551% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -68868.078% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 5.15% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 129.115% |
| Trevena, Inc. | 1.45 Million USD | -3365.563% |
| Surrozen, Inc. | -27.23 Million USD | 285.178% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 14384.403% |
| Cingulate Inc. | -582.91 Thousand USD | 8750.263% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 162757.874% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 355.972% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 666202.259% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 5823.489% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 92.592% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 5203.638% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 89596.186% |
| Kronos Bio, Inc. | 1.37 Million USD | -3575.214% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 193.959% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 17368.473% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 10426.131% |
| ImmunityBio, Inc. | -17.89 Million USD | 381.855% |
| Korro Bio, Inc. | -3.63 Million USD | 1489.089% |
| Kineta, Inc. | 5.43 Million USD | -828.105% |
| BioVie Inc. | -229.37 Thousand USD | 22082.998% |
| Codexis, Inc. | 57.33 Million USD | 12.052% |
| Celularity Inc. | 6.75 Million USD | -646.468% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1156.515% |
| Celcuity Inc. | -142.77 Thousand USD | 35417.808% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -99571.755% |
| Cibus, Inc. | 1.42 Million USD | -3445.987% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 13582.337% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 320.009% |
| IN8bio, Inc. | -2.5 Million USD | 2116.151% |
| Kodiak Sciences Inc. | -25.94 Million USD | 294.334% |
| Annexon, Inc. | -3.26 Million USD | 1643.433% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 2566.925% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 220.814% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -7778.741% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 93.523% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 70.846% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 2753.892% |
| Arcellx, Inc. | 108.27 Million USD | 53.431% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 255.778% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 36.337% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 338.389% |
| Moolec Science SA | -143.3 Thousand USD | 35286.449% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 219.155% |
| Geron Corporation | -123.5 Million USD | 140.828% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1434.041% |
| Royalty Pharma plc | 1.79 Billion USD | 97.189% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 171.942% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1396111.656% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -21691.66% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 145.258% |
| Humacyte, Inc. | -76.55 Million USD | 165.871% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 5412.402% |
| 89bio, Inc. | -273 Thousand USD | 18570.308% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 4111.451% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 6046.219% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 41095.074% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -4406.161% |
| Notable Labs, Ltd. | 113 Thousand USD | -44522.957% |
| Liquidia Corporation | 14.6 Million USD | -245.369% |
| Mustang Bio, Inc. | -2.22 Million USD | 2366.245% |
| Immunovant, Inc. | -231 Thousand USD | 21928.546% |
| Quantum-Si incorporated | 488 Thousand USD | -10232.775% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 190.757% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 168179.803% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -2608.053% |
| Acasti Pharma Inc. | -11 Thousand USD | 458499.464% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 24743.085% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 7876.024% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 130.102% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -4344.283% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 13334.63% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 2675.278% |
| PepGen Inc. | -1.18 Million USD | 4358.779% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 39803.891% |
| United Therapeutics Corporation | 2.07 Billion USD | 97.564% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 320.221% |
| Solid Biosciences Inc. | -76.56 Million USD | 165.859% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 61158.5% |
| Immuneering Corporation | -764.13 Thousand USD | 6698.8% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -75995.528% |
| Belite Bio, Inc | -399 Thousand USD | 12737.579% |
| XOMA Corporation | 3.86 Million USD | -1205.981% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 351.667% |
| Bionomics Limited | -434.44 Thousand USD | 11706.412% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 4794.967% |
| uniQure N.V. | 2.21 Million USD | -2176.476% |
| Cassava Sciences, Inc. | -89.42 Million USD | 156.388% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 154.768% |
| Forte Biosciences, Inc. | -9000.00 USD | 560366.011% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 6138.795% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 11638.659% |
| Altimmune, Inc. | -65.37 Million USD | 177.133% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 86.072% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 4794.967% |
| Compugen Ltd. | 31.45 Million USD | -60.305% |
| Peak Bio, Inc. | 367.76 Thousand USD | -13610.764% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -105.678% |
| Benitec Biopharma Inc. | 108 Thousand USD | -46588.834% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 64746.078% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 4291.516% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 2867.505% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 42473.06% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 4291.516% |
| Instil Bio, Inc. | -4.75 Million USD | 1160.217% |
| argenx SE | 1.1 Billion USD | 95.451% |
| Immunome, Inc. | -8.9 Million USD | 666.116% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2767.933% |
| Verona Pharma plc | -679.62 Thousand USD | 7519.388% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 28913.681% |
| Shattuck Labs, Inc. | -2.38 Million USD | 2214.211% |
| CervoMed Inc. | -1.29 Million USD | 3997.873% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 2194.887% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1155.557% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -1940.629% |
| Moolec Science SA | -143.3 Thousand USD | 35286.449% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 12457.9% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 1987.457% |
| AnaptysBio, Inc. | 14.78 Million USD | -241.14% |
| Design Therapeutics, Inc. | -537 Thousand USD | 9489.933% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 11908.885% |
| NeurAxis, Inc. | 2.15 Million USD | -2238.009% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -2249.671% |
| Lumos Pharma, Inc. | 2 Million USD | -2412.404% |
| Achilles Therapeutics plc | -4.73 Million USD | 1165.76% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 28913.681% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 47816.055% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -59.273% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -5748.933% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 4986.041% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 210.705% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -117164.979% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 6234.299% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 383318.886% |
| Palisade Bio, Inc. | 246 Thousand USD | -20397.537% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 152899.821% |
| Beam Therapeutics Inc. | -59.67 Million USD | 184.502% |
| Neurogene Inc. | -3.26 Million USD | 1645.798% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 63.811% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1465.762% |
| Sesen Bio, Inc. | 40 Million USD | -26.06% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 17077.758% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1352.135% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 627.116% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -258.125% |
| Athira Pharma, Inc. | -969 Thousand USD | 5303.709% |
| Vaccinex, Inc. | -16 Million USD | 415.071% |
| HCW Biologics Inc. | -574.82 Thousand USD | 8872.066% |
| XOMA Corporation | 3.86 Million USD | -1205.981% |
| Nektar Therapeutics | 53.47 Million USD | 5.711% |
| Arvinas, Inc. | 71.8 Million USD | 29.772% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 160.416% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 180.325% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 15759.609% |
| Rezolute, Inc. | -36 Thousand USD | 140166.503% |
| Clene Inc. | 533 Thousand USD | -9360.402% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 3927198.209% |
| BeyondSpring Inc. | 1.75 Million USD | -2779.723% |
| Synlogic, Inc. | -1.92 Million USD | 2720.787% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 136380.922% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 896.335% |
| Peak Bio, Inc. | 367.76 Thousand USD | -13610.764% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 365.907% |
| Krystal Biotech, Inc. | 47.6 Million USD | -5.922% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 64.261% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -903.462% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2047.458% |
| MannKind Corporation | 136.19 Million USD | 62.976% |
| Ikena Oncology, Inc. | -50.49 Million USD | 199.865% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 53.66% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1249.919% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 20109.5% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1008578.82% |
| Legend Biotech Corporation | 140.92 Million USD | 64.22% |
| Mural Oncology plc | -2.56 Million USD | 2064.314% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 9251.35% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 50523.941% |
| Champions Oncology, Inc. | 20.75 Million USD | -142.96% |
| REGENXBIO Inc. | 53.02 Million USD | 4.913% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1041.28% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 26311.275% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 3011.313% |
| Vaxart, Inc. | -60.76 Million USD | 182.985% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 19288.652% |
| Cellectis S.A. | 18 Thousand USD | -280033.006% |
| Longeveron Inc. | 221 Thousand USD | -22716.263% |
| Repare Therapeutics Inc. | -80.07 Million USD | 162.975% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 95.387% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 3996.75% |
| Revolution Medicines, Inc. | -399.66 Million USD | 112.617% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 144168.403% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -102806.002% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.414% |
| Denali Therapeutics Inc. | -93.34 Million USD | 154.019% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 201401.214% |
| Veru Inc. | 7.56 Million USD | -566.461% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 33493.338% |
| Cingulate Inc. | -582.91 Thousand USD | 8750.263% |
| Passage Bio, Inc. | -3.72 Million USD | 1455.118% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 418764.406% |
| Exicure, Inc. | -1.42 Million USD | 3643.496% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 13265.52% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1765.481% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 9935.459% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 25.984% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 33804.266% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 185.167% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -12796.149% |
| OmniAb, Inc. | 14.66 Million USD | -243.792% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -152.208% |
| Lipocine Inc. | -2.85 Million USD | 1868.753% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 2835.971% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 983.855% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3447.556% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 33.05% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 77675.294% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 40.182% |
| Ocugen, Inc. | -33.53 Million USD | 250.353% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1694.685% |
| Q32 Bio Inc. | 578 Thousand USD | -8623.865% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 19127.902% |
| Alumis Inc. Common Stock | -1.28 Million USD | 4027.098% |
| Equillium, Inc. | 35.95 Million USD | -40.23% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 3053.951% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -9971.112% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1219837.325% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 19568.703% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -11828.675% |
| Dominari Holdings Inc. | 2.03 Million USD | -2372.974% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 27583.33% |
| vTv Therapeutics Inc. | -13.59 Million USD | 470.901% |
| Bio-Techne Corporation | 773.07 Million USD | 93.477% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -191.148% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 89.057% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 4413.425% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 310.275% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -331.084% |
| Nkarta, Inc. | -5.86 Million USD | 959.157% |
| BioCardia, Inc. | -7.24 Million USD | 795.599% |
| Iterum Therapeutics plc | -1.75 Million USD | 2981.368% |